et al. Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden. Genome Med 9, 34 (2017). Acknowledgements We would like to thank the patients and their families; clinical staff and study coordinators; Bristol Myers Squibb for providing ipilimumab and nivolumab; and K. Caldwell, A.